Orelabrutinib
Drug timelines are a Plus or Pro feature.
66 regulatory and trial events tracked for Orelabrutinib, covering 2021-05-24 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL) [Phase 2]